Federation Des Caisses Desjardins Du Quebec Biotechnology

Federation Des Caisses Desjardins Du Quebec

$19 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
SILO Silo Pharma, Inc.	$1.91M	$7,000 0.0% of portfolio	6,000	Q3 2024 New
VERV Verve Therapeutics, Inc.	$669M	$7,000 0.0% of portfolio	1,700	Q2 2024 New
EDIT Editas Medicine, Inc.	$196M	$6,000 0.0% of portfolio	5,500	Q1 2025 Added 1,000.0%
EPIX Essa Pharma Inc.	$75.8M	$6,000 0.0% of portfolio	4,050	Q3 2024 Added 97.56%
CDXC Chroma Dex Corp.	$420M	$6,000 0.0% of portfolio	1,000	Q4 2024 Reduced 50.0%
NVAX Novavax Inc	$545M	$6,000 0.0% of portfolio	955	Q1 2025 Added 2.69%
WVE Wave Life Sciences Ltd.	$601M	$6,000 0.0% of portfolio	850	Q1 2025 New
ATAI Atai Life Sciences N.V.	$456M	$4,000 0.0% of portfolio	3,150	Q4 2024 Added 2,000.0%
RNA Avidity Biosciences, Inc.	$1.5B	$4,000 0.0% of portfolio	165	Q1 2024 New
PCVX Vaxcyte, Inc.	$2.16B	$4,000 0.0% of portfolio	106	Q1 2025 Added 89.29%
HALO Halozyme Therapeutics, Inc.	$8.03B	$4,000 0.0% of portfolio	75	Q1 2025 New
INMB Inmune Bio, Inc.	$41.5M	$3,000 0.0% of portfolio	400	Q1 2021 Reduced 50.0%
SRPT Sarepta Therapeutics, Inc.	$1.68B	$3,000 0.0% of portfolio	50	Q3 2024 New
OCGN Ocugen, Inc.	$210M	$3,000 0.0% of portfolio	5,310	Q1 2025 New
ABUS Arbutus Biopharma Corp	$471M	$2,000 0.0% of portfolio	800	Q2 2017 Reduced 20.0%
ARCT Arcturus Therapeutics Holdings Inc.	$355M	$2,000 0.0% of portfolio	235	Q1 2025 Reduced 4.08%
OMER Omeros Corp	$193M	$2,000 0.0% of portfolio	300	Q3 2018 Reduced 37.33%
TNYA Tenaya Therapeutics, Inc.	$24.4M	$2,000 0.0% of portfolio	4,800	Q4 2024 Added 380.0%
XLO Xilio Therapeutics, Inc.	$19.2M	$2,000 0.0% of portfolio	3,300	Q4 2024 New
ABOS Acumen Pharmaceuticals, Inc.	$49M	$1,000 0.0% of portfolio	1,500	Q3 2024 New
ARDX Ardelyx, Inc.	$693M	$1,000 0.0% of portfolio	250	Q3 2024 New
BGNE Bei Gene, Ltd.	$23.5B	$1,000 0.0% of portfolio	5	Q3 2024 New
HRMY Harmony Biosciences Holdings, Inc.	$2.05B	$1,000 0.0% of portfolio	49	Q3 2024 New
ANIX Anixa Biosciences Inc	$97.2M	$1,000 0.0% of portfolio	600	Q1 2025 New
AKBA Akebia Therapeutics, Inc.	$678M	$0 0.0% of portfolio	150	Q1 2018 Sold Out
ALEC Alector, Inc.	$138M	$0 0.0% of portfolio	415	Q3 2024 Reduced 8.79%
APLT Applied Therapeutics Inc.	$17.8M	$0 0.0% of portfolio	84	Q1 2024 New
BCYC Bicycle Therapeutics PLC	$213M	$0 0.0% of portfolio	61	Q2 2024 New
BDTX Black Diamond Therapeutics, Inc.	$90.8M	$0 0.0% of portfolio	280	Q1 2024 New
CABA Cabaletta Bio, Inc.	$43.8M	$0 0.0% of portfolio	340	Q1 2024 New
CRBU Caribou Biosciences, Inc.	$94.3M	$0 0.0% of portfolio	900	Q3 2023 Reduced 44.44%
DYN Dyne Therapeutics, Inc.	$423M	$0 0.0% of portfolio	20	Q3 2024 New
FATE Fate Therapeutics Inc	$111M	$0 0.0% of portfolio	95	Q4 2021 Reduced 33.68%
GOSS Gossamer Bio, Inc.	$117M	$0 0.0% of portfolio	750	Q3 2024 Reduced 5.06%
GLSI Greenwich Life Sciences, Inc.	$131M	$0 0.0% of portfolio	100	Q3 2024 New
KYMR Kymera Therapeutics, Inc.	$2.46B	$0 0.0% of portfolio	10	Q1 2025 New
NKTX Nkarta, Inc.	$82.2M	$0 0.0% of portfolio	100	Q2 2024 New
PLX Protalix Bio Therapeutics, Inc.	$72.1M	$0 0.0% of portfolio	250	Q4 2019 Added 340.0%
QSI Quantum Si Inc	$225M	$0 0.0% of portfolio	50	Q1 2025 Reduced 99.19%
RPTX Repare Therapeutics Inc.	$59.6M	$0 0.0% of portfolio	859	Q1 2025 Reduced 22.54%
VERA Vera Therapeutics, Inc.	$619M	$0 0.0% of portfolio	20	Q3 2024 New
VIR Vir Biotechnology, Inc.	$730M	$0 0.0% of portfolio	100	Q3 2024 Reduced 60.0%
ALLO Allogene Therapeutics, Inc.	$186M	$0 0.0% of portfolio	100	Q1 2025 New
IMNM Immunome Inc.	$104M	$0 0.0% of portfolio	141	Q1 2025 New
LEXX Lexaria Bioscience Corp.	$5.24M	$0 0.0% of portfolio	382	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.